日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patient-Reported Symptoms and Quality of Life With Sacituzumab Govitecan Versus Docetaxel in Metastatic NSCLC: The Phase 3, Randomized EVOKE-01 Trial

Sacituzumab Govitecan 与多西他赛治疗转移性非小细胞肺癌的患者报告症状和生活质量:3 期随机 EVOKE-01 试验

Reinmuth, Niels; Couraud, Sébastien; Paz-Ares, Luis; Garassino, Marina Chiara; Baijal, Shobhit; Daniel, Davey; Garrido, Pilar; Kato, Terufumi; Percent, Ivor; Rittmeyer, Achim; Parra, Hector Soto; Mekan, Sabeen; Patel, Mira; Radford, Matthew; Zhang, Eric; Pelligra, Christopher G; Guo, Shien; Felip, Enriqueta

Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial

纳武利尤单抗联合伊匹木单抗治疗晚期非透明细胞肾细胞癌患者的安全性和有效性:来自3b/4期CheckMate 920试验的结果

Tykodi, Scott S; Gordan, Lucio N; Alter, Robert S; Arrowsmith, Edward; Harrison, Michael R; Percent, Ivor; Singal, Rakesh; Van Veldhuizen, Peter; George, Daniel J; Hutson, Thomas; Zhang, Joshua; Zoco, Jesus; Johansen, Jennifer L; Rezazadeh Kalebasty, Arash

Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer

恩扎卢胺联合沙莫托利西布(LY3023414)或安慰剂治疗转移性去势抵抗性前列腺癌患者的Ib/II期研究

Sweeney, Christopher J; Percent, Ivor J; Babu, Sunil; Cultrera, Jennifer L; Mehlhaff, Bryan A; Goodman, Oscar B; Morris, David S; Schnadig, Ian D; Albany, Costantine; Shore, Neal D; Sieber, Paul R; Guba, Susan C; Zhang, Wei; Wacheck, Volker; Donoho, Gregory P; Szpurka, Anna M; Callies, Sophie; Lin, Boris Kin; Bendell, Johanna C

Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial

Telaglenastat联合Everolimus治疗晚期肾细胞癌:一项随机、双盲、安慰剂对照的II期ENTRATA试验

Lee, Chung-Han; Motzer, Robert; Emamekhoo, Hamid; Matrana, Marc; Percent, Ivor; Hsieh, James J; Hussain, Arif; Vaishampayan, Ulka; Liu, Sandy; McCune, Steven; Patel, Vijay; Shaheen, Montaser; Bendell, Johanna; Fan, Alice C; Gartrell, Benjamin A; Goodman, Oscar B; Nikolinakos, Petros G; Kalebasty, Arash Rezazadeh; Zakharia, Yousef; Zhang, Zhentao; Parmar, Hema; Akella, Lalith; Orford, Keith; Tannir, Nizar M

Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451

纳武利尤单抗和伊匹木单抗作为广泛期小细胞肺癌的维持治疗:CheckMate 451

Owonikoko, Taofeek K; Park, Keunchil; Govindan, Ramaswamy; Ready, Neal; Reck, Martin; Peters, Solange; Dakhil, Shaker R; Navarro, Alejandro; Rodríguez-Cid, Jerónimo; Schenker, Michael; Lee, Jong-Seok; Gutierrez, Vanesa; Percent, Ivor; Morgensztern, Daniel; Barrios, Carlos H; Greillier, Laurent; Baka, Sofia; Patel, Miten; Lin, Wen Hong; Selvaggi, Giovanni; Baudelet, Christine; Baden, Jonathan; Pandya, Dimple; Doshi, Parul; Kim, Hye Ryun

Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone receptor-positive breast cancer

一项针对新诊断为雌激素受体或孕激素受体阳性乳腺癌的绝经后女性患者的术前(新辅助)来曲唑联合贝伐单抗的试点试验

Forero-Torres, Andres; Saleh, Mansoor N; Galleshaw, Janice A; Jones, Cheryl F; Shah, Jatin J; Percent, Ivor J; Nabell, Lisle M; Carpenter, John T; Falkson, Carla I; Krontiras, Helen; Urist, Marshall M; Bland, Kirby I; De Los Santos, Jennifer F; Meredith, Ruby F; Caterinicchia, Valerie; Bernreuter, Wanda K; O'Malley, Janis P; Li, Yufeng; LoBuglio, Albert F